FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Published: 08 Sep 2022

  • Views:

    Views Icon 10763
  • Likes:

    Heart Icon 0

In this video, Dr Michelle L O’Donoghue summarises the FOURIER-OLE trial design, highlighting the key results, safety profile and take home-messages.


This video is part of a series of interviews, recorded at ESC Congress 2022 in Barcelona, in which Dr Michelle L O’Donoghue, Dr Marc S Sabatine and Dr Robert P Giugliano consider the importance and implications of the FOURIER-OLE trial.

Watch next:

FOURIER-OLE: The Trial in Context

FOURIER-OLE: Implications for Real-World Practice


This programme is supported by an unrestricted educational grant from Amgen.